NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS

Basit Öğe Kaydı
dc.contributor.authorTanaka, Ryuma
dc.contributor.authorSullivan, Michael
dc.contributor.authorCanpolat, Cengiz
dc.contributor.authorJohnston, Robert
dc.contributor.authorAtaseven, Eda
dc.contributor.authorAtes, Dilvin Celik
dc.contributor.authorDuncan, Catriona
dc.date.accessioned2024-08-04T21:00:02Z
dc.date.available2024-08-04T21:00:02Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS432en_US
dc.identifier.issn1545-5009
dc.identifier.issn1545-5017
dc.identifier.startpageS432en_US
dc.identifier.urihttps://hdl.handle.net/11616/103736
dc.identifier.volume70en_US
dc.identifier.wosWOS:001183650902072en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatric Blood & Canceren_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleNAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORSen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu